uniQure N.V. (QURE) stock
QURENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30224% above fair value
$20.30−0.48 (-2.31%)
Close on Nov 18, 2026Market cap $1.41BP/E –Yield –
uniQure gross margin
Gross margin is gross profit as a percentage of revenue.
uniQure's gross margin for the twelve months ending Jun 30, 2026 was 92.5%. For fiscal 2025 it was 89.5%, against 95.3% the year before. The highest annual figure on record is 99.6% in fiscal 2023.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 89.5% | −5.8 |
| FY2024 | Dec 31, 2024 | 95.3% | −4.3 |
| FY2023 | Dec 31, 2023 | 99.6% | +0.8 |
| FY2022 | Dec 31, 2022 | 98.8% | +3.6 |
| FY2021 | Dec 31, 2021 | 95.2% | +3.0 |
| FY2020 | Dec 31, 2020 | 92.3% | +15.0 |
| FY2019 | Dec 31, 2019 | 77.3% | −12.1 |
| FY2018 | Dec 31, 2018 | 89.3% | −4.4 |
| FY2017 | Dec 31, 2017 | 93.8% | −0.9 |
| FY2016 | Dec 31, 2016 | 94.6% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 94.0% | +6.5 |
| Q1 FY2026 | Mar 31, 2026 | 93.9% | +6.4 |
| Q4 FY2025 | Dec 31, 2025 | 92.2% | +4.0 |
| Q3 FY2025 | Sep 30, 2025 | 89.2% | +0.8 |
| Q2 FY2025 | Jun 30, 2025 | 87.5% | −10.4 |
| Q1 FY2025 | Mar 31, 2025 | 87.4% | −10.8 |
| Q4 FY2024 | Dec 31, 2024 | 88.1% | −8.7 |
| Q3 FY2024 | Sep 30, 2024 | 88.5% | −11.5 |
| Q2 FY2024 | Jun 30, 2024 | 97.9% | +2.9 |
| Q1 FY2024 | Mar 31, 2024 | 98.2% | – |
| Q4 FY2021 | Dec 31, 2021 | 96.9% | – |
| Q3 FY2021 | Sep 30, 2021 | 100.0% | – |
| Q2 FY2021 | Jun 30, 2021 | 95.0% | – |
See a number that looks wrong?